1,333
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Knowledge of cytomegalovirus and available prevention strategies in pregnancy: a cross-sectional study in Portugal

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2183754 | Received 11 Jun 2022, Accepted 16 Feb 2023, Published online: 01 Mar 2023

References

  • Leruez-Ville M, Foulon I, Pass R, et al. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020;223(3):330–349.
  • Smithers-Sheedy H, Raynes-Greenow C, Badawi N, et al. Congenital cytomegalovirus among children with cerebral palsy. J Pediatr. 2017;181:267–271.e1.
  • Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–213.
  • Lito D, Francisco T, Salva I, et al. [TORCH serology and group B Streptococcus screening analysis in the population of a maternity]. Acta Med. Port. 2013;26(5):549–554.
  • Practice bulletin no. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet. Gynecol. 2015;125(6):1510–1525.
  • Boucoiran I, Yudin M, Poliquin V, et al. Guideline no. 420: cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can. 2021;43(7):893–908.
  • Mussi-Pinhata MM, Yamamoto AY, Aragon DC, et al. Seroconversion for cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: ‘the BraCHS study. J Infect Dis. 2018;218(8):1200–1204.
  • De Vries JJC, Van Zwet EW, Dekker FW, et al. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol. 2013;23(4):241–249.
  • Hughes BL, Gans KM, Raker C, et al. A brief prenatal intervention of behavioral change to reduce the risk of maternal cytomegalovirus: a randomized controlled trial. Obstet Gynecol. 2017;130(4):726–734. Oct
  • Wizman S, et al. Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in montreal, Canada. BMC Pregnancy Childbirth. 2016;16:54.
  • Beaudoin ML, Renaud C, Boucher M, et al. Perspectives of women on screening and prevention of CMV in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2021;258:409–413.
  • Peng C, Yue C, Avitt A, et al. A systematic review approach to find robust items of the Zimbardo time perspective inventory. Front. Psychol. 2021;12:1–8.
  • Zimbardo P, Boyd J. Putting time in perspective: a valid, reliable individual-differences metric. J. Pers. Soc. Psychol. 1999;77(6):1271–1288.
  • Sobol-Kwapińska M, Jankowski T, Przepiorka A, et al. What is the structure of time? A study on time perspective in the United States, Poland, and Nigeria. Front Psychol. 2018;9:2078. Online]. Available https://doi.org/10.3389/fpsyg.2018.02078.
  • Henson JM, Carey MP, Carey KB, et al. Associations among health behaviors and time perspective in young adults: model testing with boot-strapping replication. J Behav Med. 2006;29(2):127–137.
  • Siegel AM, Clinton CM, Post AL, et al. Assessing patient perceptions of cytomegalovirus infection in pregnancy. J. Med. Virol. 2020;92(12):3658–3664.
  • Vauloup-Fellous C, Picone O, Cordier A-G, et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol. 2009;46(Suppl 4):S49–S53.
  • Crockett RA, Weinman J, Hankins M, et al. Time orientation and health-related behaviour: measurement in general population samples. Psychol Health. 2009;24(3):333–350.
  • Demmler-Harrison GJ. Congenital cytomegalovirus: public health action towards awareness, prevention, and treatment. J Clin Virol. 2009;46(Suppl 4):S1–S5.
  • Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy–United States, 2007. MMWR. Morb. Mortal. Wkly. Rep. 2008;57(3):65–68.
  • Shand AW, Luk W, Nassar N, et al. Cytomegalovirus (CMV) infection and pregnancy-potential for improvements in Australasian maternity health providers’ knowledge. J. Matern. Neonatal Med. 2018;31(19):2515–2520.
  • Fellah T, Sibiude J, Vauloup-Fellous C, et al. Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 2018. No. J Clin Virol. 2020;129:104335.
  • Smithers-Sheedy H, Swinburn K, Waight E, et al. eLearning significantly improves maternity professionals’ knowledge of the congenital cytomegalovirus prevention guidelines. Aust N Z J Obstet Gynaecol. 2022;62(3):445–452.
  • Silva AJ. Programa Nacional Para a Vigilância da Gravidez de Baixo Risco. In Gráfica Ma. Lisboa, editor. Direção-Geral da Saúde; 2015.
  • Leruez-Ville M, Ville Y. Is it time for routine prenatal serological screening for congenital cytomegalovirus? Prenat Diagn. 2020;40(13):1671–1680.